Patient-Derived Ovarian Cancer Organoid Model

[sherwinbrown]

The patient-Derived Xenografts (PDX) are preclinical cancer models developed by implanting tumor tissues directly from a patient into immunocompromised or humanized mice. These models preserve the original tumor's histological architecture, genetic makeup, and heterogeneity, making them valuable tools for studying cancer biology, drug testing, and personalized medicine.